AU3957600A - Piperidyl-imidazole derivatives, their preparations and therapeutic uses - Google Patents

Piperidyl-imidazole derivatives, their preparations and therapeutic uses

Info

Publication number
AU3957600A
AU3957600A AU39576/00A AU3957600A AU3957600A AU 3957600 A AU3957600 A AU 3957600A AU 39576/00 A AU39576/00 A AU 39576/00A AU 3957600 A AU3957600 A AU 3957600A AU 3957600 A AU3957600 A AU 3957600A
Authority
AU
Australia
Prior art keywords
piperidyl
preparations
therapeutic uses
imidazole derivatives
imidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39576/00A
Other languages
English (en)
Inventor
Knud Erik Andersen
Florencio Zaragoza Dorwald
Tine Krogh Jorgensen
Ingrid Pettersson
Birgitte Schjellerup Wulff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Novo Nordisk AS
Original Assignee
Boehringer Ingelheim International GmbH
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH, Novo Nordisk AS filed Critical Boehringer Ingelheim International GmbH
Publication of AU3957600A publication Critical patent/AU3957600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU39576/00A 1999-04-26 2000-04-14 Piperidyl-imidazole derivatives, their preparations and therapeutic uses Abandoned AU3957600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199900565 1999-04-26
DKPA199900565 1999-04-26
PCT/DK2000/000186 WO2000064884A1 (fr) 1999-04-26 2000-04-14 Derives de piperidyle-imidazole, preparations dans lesquelles ils entrent et utilisations therapeutiques de ces dernieres

Publications (1)

Publication Number Publication Date
AU3957600A true AU3957600A (en) 2000-11-10

Family

ID=8094986

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39576/00A Abandoned AU3957600A (en) 1999-04-26 2000-04-14 Piperidyl-imidazole derivatives, their preparations and therapeutic uses

Country Status (2)

Country Link
AU (1) AU3957600A (fr)
WO (1) WO2000064884A1 (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1421071B1 (fr) 2001-07-02 2009-11-18 High Point Pharmaceuticals, LLC Derives de piperazines et diazepane substituees comme modulateurs du recepteur d'histamine h3
EP1416046A4 (fr) * 2001-07-02 2006-01-18 Banyu Pharma Co Ltd Utilisation du gene h3 du recepteur d'histamine pour controler le poids corporel ou l'alimentation
BR0215212A (pt) 2001-12-21 2004-12-07 Novo Nordisk As Ativador de carboxamida ou sulfonamida de glicoquinase, composto, composição farmacêutica, e, uso de um composto
AU2003235687A1 (en) * 2002-01-11 2003-07-30 Abbott Laboratories Histamine-3 receptor ligands for diabetic conditions
US7314937B2 (en) 2002-03-21 2008-01-01 Eli Lilly And Company Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses
KR101116627B1 (ko) 2002-06-27 2012-10-09 노보 노르디스크 에이/에스 치료제로서 아릴 카르보닐 유도체
MXPA06003474A (es) 2003-09-30 2006-06-05 Novo Nordisk As Agonistas de receptores de melanocortina.
GB0325287D0 (en) * 2003-10-29 2003-12-03 Merck Sharp & Dohme Therapeutic agents
EP1694356B1 (fr) 2003-12-09 2011-02-16 Novo Nordisk A/S Regulation d'une preference alimentaire au moyen d'agonistes de glp-1
DK1723128T3 (da) 2004-01-06 2013-02-18 Novo Nordisk As Heteroarylurinstoffer og deres anvendelse som glucokinaseaktivatorer
CN1950078A (zh) 2004-06-11 2007-04-18 诺和诺德公司 使用glp－1激动剂抵抗药物诱发的肥胖
CN1989115B (zh) * 2004-07-26 2012-03-21 伊莱利利公司 作为组胺h3受体药物的噁唑衍生物及其制备和制药用途
CA2590720A1 (fr) 2004-12-03 2006-06-08 Lone Jeppesen Composes heteroaromatiques activants de glucokinase
JP4960355B2 (ja) 2005-07-14 2012-06-27 ノボ・ノルデイスク・エー／エス ウレア型グルコキナーゼ活性化剤
AU2007260836B2 (en) 2006-06-23 2012-11-15 Abbvie Bahamas Ltd. Cyclopropyl amine derivatives as histamin H3 receptor modulators
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
AU2007283113A1 (en) 2006-08-08 2008-02-14 Sanofi-Aventis Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
AU2008204530B2 (en) 2007-01-11 2013-08-01 Vtv Therapeutics Llc Urea glucokinase activators
EP2025674A1 (fr) 2007-08-15 2009-02-18 sanofi-aventis Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
UY31968A (es) 2008-07-09 2010-01-29 Sanofi Aventis Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
WO2010068601A1 (fr) 2008-12-08 2010-06-17 Sanofi-Aventis Hydrate de fluoroglycoside hétéroaromatique cristallin, ses procédés de fabrication, ses procédés d'utilisation et compositions pharmaceutiques le contenant
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
CA2771278A1 (fr) 2009-08-26 2011-03-03 Sanofi Nouveaux hydrates de fluoroglycoside heteroaromatiques cristallins, substances pharmaceutiques comprenant ces composes et leur utilisation
BR112012021231A2 (pt) 2010-02-26 2015-09-08 Basf Plant Science Co Gmbh método para acentuar o rendimento em plantas, planta, construto, uso de um construto, método para a produção de uma planta transgênica, partes coletáveis de uma planta, produtos derivados de uma planta, uso de um ácido nucleíco e método para a produção de um produto
US20130012432A1 (en) 2010-02-26 2013-01-10 Novo Nordisk A/S Peptides for Treatment of Obesity
RU2559320C2 (ru) 2010-03-26 2015-08-10 Ново Нордиск А/С Новые аналоги глюкагона
US8853390B2 (en) 2010-09-16 2014-10-07 Abbvie Inc. Processes for preparing 1,2-substituted cyclopropyl derivatives
WO2012120052A1 (fr) 2011-03-08 2012-09-13 Sanofi Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation
US8809325B2 (en) 2011-03-08 2014-08-19 Sanofi Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8809324B2 (en) 2011-03-08 2014-08-19 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
WO2012120053A1 (fr) 2011-03-08 2012-09-13 Sanofi Dérivés oxathiazine ramifiés, procédé pour leur préparation, utilisation en tant que médicament, agents pharmaceutiques contenant ces dérivés et leur utilisation
WO2012120058A1 (fr) 2011-03-08 2012-09-13 Sanofi Dérivés d'oxathiazine substitués par des groupes benzyle ou hétérométhylène, leur procédé de production, leur utilisation comme médicament ainsi que produits pharmaceutiques les contenant et leur utilisation
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683699B1 (fr) 2011-03-08 2015-06-24 Sanofi Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
WO2012120057A1 (fr) 2011-03-08 2012-09-13 Sanofi Nouveaux dérivés phényl-oxathiazine substitués, procédé pour leur préparation, agent pharmaceutique contenant ces composés et leur utilisation
AU2012234276A1 (en) 2011-03-28 2013-08-29 Novo Nordisk A/S Novel glucagon analogues
TWI596110B (zh) 2011-09-23 2017-08-21 諾佛 儂迪克股份有限公司 新穎升糖素類似物
WO2014170496A1 (fr) 2013-04-18 2014-10-23 Novo Nordisk A/S Co-agonistes stables du récepteur du glucagon/glp -1 à action retardée et à usage médical
CN106536547A (zh) 2014-06-04 2017-03-22 诺和诺德股份有限公司 用于医疗用途的glp‑1/胰高血糖素受体共激动剂
CN111032680A (zh) 2017-03-15 2020-04-17 诺和诺德股份有限公司 能够与黑皮质素4受体结合的双环化合物
WO2019219714A1 (fr) 2018-05-15 2019-11-21 Novo Nordisk A/S Composés capables de se lier au récepteur de la mélanocortine 4
WO2020053414A1 (fr) 2018-09-14 2020-03-19 Novo Nordisk A/S Composés bicycliques aptes à se lier aux agonistes du récepteur de la mélanocortine 4

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2579596B1 (fr) * 1985-03-26 1987-11-20 Inst Nat Sante Rech Med (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique
CA2133461A1 (fr) * 1992-04-01 1993-10-14 Graham J. Durant Imidazoles substituees par des groupes 4-[4'piperidinyl ou 3'-pirrolidinyl], utilisees comme antagonistes du recepteur h3, et utilisations therapeutiques de celles-ci
US5486526A (en) * 1992-04-01 1996-01-23 The University Of Toledo Histamine H3 -receptor antagonists and therapeutic uses thereof

Also Published As

Publication number Publication date
WO2000064884A1 (fr) 2000-11-02

Similar Documents

Publication Publication Date Title
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
AU5970298A (en) Dithiolan derivatives, their preparation and their therapeutic effect
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
AU2922600A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
AU2001282267A1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
AU715620C (en) Therapeutic methods and uses
AU3301700A (en) (n)-sulfonyl-dipeptide derivatives, production and use thereof in therapy
AU3971500A (en) Indazole derivatives, preparation and therapeutic application thereof
AU1243399A (en) Imidazole derivatives, preparation and therapeutic application thereof
AU6846500A (en) Novel 8-carbonyl chroman derivatives, preparation and therapeutic use thereof
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
AU2002229870A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
AU3023497A (en) Phthalazine derivatives, their preparation and their use as drugs
AU5524400A (en) Novel 6-amino-uracil derivatives, preparation and use thereof
AU2001237518A1 (en) Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application
AU3971800A (en) 2-alkoxy-cyclobutene-3,4-dione derivatives, preparation and therapeutic use thereof
AU2526001A (en) 2-phenyl-quinoline derivatives, preparation method and therapeutic use thereof
AU1172101A (en) Phytoestrogenic pharmaceutical preparations
AU3153199A (en) Azacycloalkane derivatives, preparation and therapeutic application
HUP0202364A3 (en) Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
AU5974100A (en) 6-carboxyphenyldihydropyridazinone derivatives and use thereof
AU4504201A (en) Drug preparations
AU2922700A (en) Cyclobutene-3,4-dione derivatives, preparation method and therapeutic use
AU1566599A (en) 3-oxazol-5-yl-1-oxo-1,2-dihydroisoquinoline-4-propanamide derivatives, preparation and therapeutic application
AU6150400A (en) Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 15, NO 8, PAGE(S) 1437-1441 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 63615/99, 29371/00, 32735/00, 34186/00, 34523/00, 38461/00, 39576/00, 40954/00, 41009/00, 41529/00, 42859/00, 43031/00, 43039/00, 43123/00, 44389/00, 45394/00, 47543/00, 47881/00, 49147/00 AND 14081/01

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase